Answer
Concomitant use of abacavir + lamivudine with cladribine is not recommended because lamivudine inhibits cladribine’s intracellular phosphorylation in vitro, potentially reducing cladribine’s clinical efficacy; some clinical findings also support a possible interaction, although the interaction has not been studied.
Sources for this answer
- Abacavir/Lamivudine Dr. Reddy's 600 mg/300 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked